Business Wire

TX-FLUENCE

Share
Fluence by OSRAM Debuts Products at MJBizCon 2021, Helping Cannabis Cultivators Grow Smarter Through Innovative LED Technology

Fluence by OSRAM (Fluence), a leading global provider of energy-efficient LED lighting solutions for commercial cannabis and food production, announced today it will debut products at MJBizCon 2021, including its high-output SPYDR 2h, SPYDR Fang, waterproof RAZR Enclosed and next-generation RAPTR top light as well as its new lighting controls, Wireless Flex Dimming and the SHYFT Light Scheduler.

Following the announcement of its multiyear global research study results —which showcased the effects of broad-spectrum lighting solutions on crop yield and quality—Fluence will demo its innovative new products at the company’s MJBizCon booth, located at No. C3515.

“In our recently announced research results, Fluence noted a clear, positive impact on cannabis crop yield, cannabinoid content and overall plant quality under broad-spectrum lighting,” said David Cohen, CEO of Fluence. “According to the 2021 State of the Cannabis Lighting Market report , LED usage for cannabis cultivation has increased more than 45 percent for all stages of growth since the initial report in 2016. The efficacy of LED lighting solutions for cannabis cultivation is no longer a question. Cultivators have embraced the power of LEDs and are seeking new ways to harness broad-spectrum lighting technology to optimize their cultivation environments. Fluence’s innovative new products—informed by the latest photobiology research—will enable cultivators to achieve exceptional crop performance.”

The latest luminaires from Fluence include:

  • SPYDR 2h: An extension of Fluence’s SPYDR series—featuring luminaires designed for single- or multitier growers who want to optimize grow space—the company’s high-output SPYDR 2h produces a photosynthetic photon flux of up to 2,080 μmol/s. Supported by results from Fluence’s multiyear global research studies observing cannabis growth under high light intensities, the SPYDR 2h is designed to maximize yields.
  • SPYDR Fang: The SPYDR Fang is designed specifically for the retail buyer and built with Fluence’s trusted, research-backed and science-led engineering leveraged by commercial growers throughout the world.
  • RAZR Enclosed: Following its debut in June 2021, the RAZR Modular System is now IP67 waterproof to withstand hyper-wet and humid environments within a vertical farm. The RAZR series is also now available with various spectral options, including broad-white as well as dual red and blue light. Fluence will showcase the system’s newest features through video at the company’s MJBizCon booth.
  • RAPTR: Fluence’s latest top light solution serves as an advanced one-to-one high-pressure sodium replacement. The next-generation top light consumes 1,000 watts at a high output, plugging in seamlessly to a grower’s existing facility for streamlined retrofits.

“Fluence’s high-output SPYDR 2h will transform how cannabis cultivators approach each stage of plant production,” said Jordon Musser, chief product officer for Fluence. “We’ve seen incredible yield and quality metrics at high PPFDs and we’re excited to collaborate with our growers to incorporate high-intensity lighting and cultivation strategies into their operations.”

The company will also debut its innovative lighting controls, including:

  • SHYFT: Available in North America, Fluence’s light scheduler, SHYFT, offers patented photoacclimation capability and daily photoperiod control for 0 to 10 V LED and dimmable fluorescent fixtures. At MJBizCon, visit the Fluence booth to see SHYFT control each of the company’s luminaires and witness its advanced lighting control capabilities.
  • Wireless Flex Dimming: In addition to SHYFT, Fluence’s Wireless Flex Dimming solution leverages Bluetooth mesh technology to wirelessly control fixtures. With Wireless Flex Dimming’s plug-and-play design, growers gain increased flexibility over light levels with no wire installations or additional labor costs. Fluence team members will demo the product’s wireless capabilities from within the booth.

“MJBizCon is the world’s stage for unveiling leading cannabis innovations and we’re thrilled to debut multiple solutions that are advancing the global cannabis market forward,” said Lorrie Schultz, senior vice president of marketing for Fluence. “We’re eager to showcase our new products at MJBizCon and exemplify how Fluence is helping cannabis cultivators grow smarter.”

For more information on Fluence, its products and release dates for the company’s newest solutions, visit the team at MJBizCon from Oct. 20, 2021 to Oct. 22, 2021 at booth No. C3515 or explore Fluence’s website at www.fluence.science .

About Fluence by OSRAM

Fluence Bioengineering, Inc., a wholly-owned subsidiary of OSRAM , creates powerful and energy-efficient LED lighting solutions for commercial crop production and research applications. Fluence is a leading LED lighting supplier in the global cannabis market and is committed to enabling more efficient crop production with the world’s top vertical farms and greenhouse produce growers. Fluence global headquarters are based in Austin, Texas, with its EMEA headquarters in Rotterdam, Netherlands. For more information about Fluence, visit https://fluence.science .

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Brenus Pharma Reports Favorable Tolerability and Clinical Signals in Early Preliminary Results of First-In-Human Study for STC-1010 in Unresectable Metastatic Stage Colorectal Cancer (MSS CRC) Patients6.1.2026 21:00:00 CET | Press release

Brenus Pharma, a clinical stage biotechnology company unlocking the immune system in vivo to fight solid tumors, announced the successful completion of the first dose levels in its ongoing first-in-human study. The multi-center, open-label trial (NCT06934538) is a phase Ia/Ib study designed to evaluate safety, tolerability and preliminary clinical activity of STC-10101 in a first line setting. It will include in vivo analysis of immune and tumor dynamics during dose escalation of treatment and cohort extension to patients with unresectable locally advanced (stage IIIC, T4b) or unresectable metastatic (stage IV) MSS2 colorectal cancer (CRC). Early findings indicate that the first dose levels have been successfully completed with good overall tolerance and no-dose-limiting toxicities observed to date. “We are pleased to report that the safety profile observed to date is good and consistent with our expectations with no DLT,” said Paul Bravetti, CEO of Brenus Pharma. “Moreover, preliminar

SPIE, the International Society for Optics and Photonics, Announces Its 2026 Fellows6.1.2026 20:35:00 CET | Press release

The Society is welcoming 40 new Fellow Members from across the globe SPIE, the international society for optics and photonics, welcomes 40 Members as new Fellows of the Society in the 2026 cohort. They join their Fellow Member colleagues in being honored for their excellent technical achievements, as well as for their substantial service to the optics and photonics community and to SPIE. Fellows are Members of the Society who have made significant scientific and technical contributions in the multidisciplinary fields of optics, photonics, and imaging. Since the Society's inception in 1955, more than 1,800 SPIE Members have become Fellows. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260106630672/en/ SPIE, the international society for optics and photonics, announces its 2026 Fellows This year’s inductees are high-profile leaders in academia, industry, and government, many of whom are particularly prominent in their support

Chemelex Adds Electric Heat Trace Group Ltd.’s SmartTrace Monitoring Platform to its Heat Tracing Portfolio6.1.2026 20:00:00 CET | Press release

Chemelex, a global leader in electric thermal and sensing solutions, today announced the successful completion of its acquisition of substantially all the assets and ongoing operations of Electric Heat Trace Group Ltd. (EHT Group), headquartered in Ontario, Canada. This strategic move marks an exciting start to the new year and reinforces Chemelex’s commitment to delivering smarter, data-driven solutions for industrial heat trace systems. EHT Group is a recognized innovator in heat trace management, offering advanced software, integrated controller solutions, wireless communication modules, and comprehensive field services. Its flagship platform, SmartTrace, is a robust solution available in both cloud-based and on-premises deployments that enables predictive maintenance, minimizes downtime, and provides secure remote monitoring—helping customers achieve greater reliability and operational efficiency. This endeavor will help Chemelex support greater operational efficiencies for our cus

ZIIHERA Plus TEVIMBRA and Chemotherapy: A Potential New Standard for First-Line HER2+ Advanced GEA6.1.2026 19:30:00 CET | Press release

Combination therapy showed compelling survival and disease control compared to current standard, regardless of PD-L1 statusHigh GEA burden in Asia, where BeOne holds ZIIHERA rights, signals potential broad patient impactResults to be presented as a Late-Breaking Abstract Oral Presentation at ASCO GI on January 8, 2026 BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced full results from the Phase 3 HERIZON-GEA-01 trial evaluating ZIIHERA® (zanidatamab), a HER2-targeted bispecific antibody, in combination with chemotherapy, with and without PD-1 inhibitor TEVIMBRA® (tislelizumab), as a first-line treatment for HER2-positive (HER2+) locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). These data, including the first interim overall survival (OS) analysis, will be presented as a Late-Breaking Abstract Oral Presentation (#LBA285) at the American Society of Clinical Oncology Gastrointestinal Cancers Symposium (ASCO GI) on

Siemens and NVIDIA Expand Partnership to Build the Industrial AI Operating System6.1.2026 18:07:00 CET | Press release

Through AI, Siemens and NVIDIA are reinventing the entire end-to-end industrial value chain – from design and engineering to manufacturing, production, operations, and into supply chainsSiemens and NVIDIA to build AI-accelerated portfolio including AI-native electronic design, AI native simulation as well as AI driven adaptive manufacturing and supply chainSiemens and NVIDIA to design the next generation of AI factoriesSiemens and NVIDIA to optimize operations through shared innovation CES 2026 - Siemens and NVIDIA today announced a significant expansion of their strategic partnership to bring artificial intelligence into the real world. Together, the companies aim to develop industrial and physical AI solutions that will bring AI-driven innovation to every industry and industrial workflow, as well as accelerate each others’ operations. To support development, NVIDIA will provide AI infrastructure, simulation libraries, models, frameworks and blueprints, while Siemens will commit hundr

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye